Treatment of primary open angle glaucoma:
**Core Concept**
Primary open-angle glaucoma (POAG) is a chronic progressive optic neuropathy characterized by increased intraocular pressure (IOP) due to impaired aqueous humor drainage, leading to optic nerve damage and potential vision loss. The goal of treatment is to reduce IOP and prevent further optic nerve damage.
**Why the Correct Answer is Right**
The treatment of POAG typically involves a combination of medical and surgical interventions to reduce IOP. **Option C: Prostaglandin analogs** are a class of medications that work by increasing the outflow of aqueous humor through the trabecular meshwork, thereby reducing IOP. This is achieved through the activation of prostaglandin receptors, specifically the EP2 receptor, which leads to the relaxation of the trabecular meshwork and increased aqueous outflow.
**Why Each Wrong Option is Incorrect**
**Option A:** Beta-blockers are used to reduce IOP by decreasing the production of aqueous humor, but they are not the primary treatment for POAG.
**Option B:** Systemic carbonic anhydrase inhibitors are used to treat glaucoma, but they are not the first-line treatment for POAG.
**Option D:** Laser trabeculoplasty is a surgical procedure used to treat POAG, but it is not a medication.
**Clinical Pearl / High-Yield Fact**
The IOP reduction goal for POAG treatment is typically 20-30% from baseline, achieved through a combination of medications and/or surgery.
**Correct Answer: C. Prostaglandin analogs**